Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 188 results for "bse healthcare"

Closing Bell: Healthcare in sell-spree as smallcap shines and Sensex ends flat
Sify

Closing Bell: Healthcare in sell-spree as smallcap shines and ...

Healthcare stocks witnessed selling pressure amid a flat day for Indian benchmark indices. The thirty scrip sensitive BSE Sensex made a 32.12 point or 0.10% gain, while the fifty scrip sensitive Nifty on the NSE made a 5.80 point of 0.06% intra-day gain. On ... Sify, 1 week ago
[x]  

13 images for bse healthcare

Sify, 1 week ago
Sify, 2 months ago
Money Control, 2 months ago
Money Today, 2 months ago
Sify, 2 months ago
Money Control, 4 months ago
Money Control, 4 months ago
Money Control, 4 months ago
Money Control, 5 months ago
Sify, 5 months ago
Sify

Cadila Healthcare recovers after getting USFDA nod for drug

Cadila Healthcare gained 1.36% to Rs 498.05 at 14:#0 IST on BSE after the company said that it received final approval from the US drug regulator to market Desvenlafaxine Extended-Release Tablets, 50 mg and 100 mg.
 Business Standard1 month ago Cadila Healthcare advances after receiving USFDA nod for drugs  Business Standard1 month ago Eris Lifesciences acquires UTH Healthcare  Business Standard1 month ago Cadila Healthcare in pink of health after USFDA nod for influenza drug  Business Standard2 months ago
Money Control

This week in pharma: Sun Pharma get EIR for Dadra plant, Lupin acquires Symbiomix Therapeutics

The BSE Healthcare index rose 0.54 percent in the past week while the benchmark Sensex gained 1.79 percent.
 Money Control1 month ago Pharma weekly wrap: Pharma stocks gain on investor interest due to cheap valuations  Money Control2 months ago Pharma shares extend gain; Sun Pharma, Divi's Lab up over 10% in three days  Business Standard2 months ago This week in pharma: Lupin, Cadila, Strides Shasun get clearances from US FDA  Money Control2 months ago
Sify

Returns of BSE Healthcare Index vis a vis Sensex

BSE Healthcare Index is down 24% in two years. This is a mighty fall compared to the benchmark index, which is up 23% during the same period. A downgrade in earnings estimates has led to the selloff in the pharma space. USFDA alerts on Indian pharma companies ...
 Equitymaster.com2 months ago Sensex, Nifty edge higher; Airtel jumps  Sify2 weeks ago Indian shares edge higher; Airtel jumps  Sify2 weeks ago Indian shares range-bound; banks, realty gain  Sify2 months ago

Aster DM Healthcare to raise $150 million in minority listing on India's BSE

DUBAI (Reuters) - United Arab Emirates-based Aster DM Healthcare expects to raise around $150 million from listing a 10 percent stake on the Bombay Stock Exchange by March 2018, its managing director said on Monday. The company filed a prospectus for an ...
 Sify2 weeks ago

Cadila Healthcare extends gains after receiving USFDA nod for drug

Cadila Healthcare rose 0.38% to Rs 505.30 at 10:05 IST on BSE, with the stock extending previous session's gains triggered by the company receiving final approval from the US drug regulator to market Itraconazole Capsules 100 mg.
 Business Standard1 month ago Cadila inches up after FDA approval for drug  Business Standard2 months ago Cadila Healthcare gains after USFDA approval for drug  Business Standard2 months ago Cadila Healthcare up 7% on USFDA approval for antipsychotic drug  Business Standard2 months ago
Rediff.com

Sensex rises for 3rd day; Nifty above 10,000

Stocks of IT, power, healthcare, capital goods, oil & gas, banking and auto were the major drivers. The benchmark BSE Sensex rose by 78 points to end at over two-week high of 31,924.41, marking its third straight day of gains as pharma, oil and gas and banking stocks advanced.   The broader NSE Nifty closed above the 10,000-mark for the first time since September 21, gaining 28.20 points, or 0.28 per cent to 10,016.95 after shuttling between 10,034 and 10,002.30. Sustained buying by ...
 Rediff.com1 month ago Sensex gains 84 points at close on F&O expiry  Rediff.com2 months ago
Sify

Re-rating likely of pharma stocks

The BSE Healthcare index has been one of the biggest gainers over the past few days, on easing of regulatory concerns, improving visibility over product launches and a return of growth in the domestic market.Ranjit Kapadia of Centrum Broking believes there ...
 Business Standard1 month ago Pharma stocks in demand as investors react to some positive news  Sify2 months ago

Jaiprakash Associates leads gainers on BSE's 'A' group

Central Bank of India, Firstsource Solutions, Ujjivan Financial Services and Fortis Healthcare are among the other gainers in the BSE's 'A' group today, 30 August 2017.
 Business Standard2 months ago Trent leads gainers in 'A' group  Business Standard2 months ago
Sify

Sell-off in healthcare stocks suppress key indices

Heavy selling pressure in healthcare, auto and capital goods counters suppressed the key Indian equity indices during the mid-afternoon trade session on Thursday. At 1.10 p.m. the S&P BSE Sensex traded lower by 22 points or 0.07 per cent. Similarly, the NSE ...
 Sify1 week ago Short-covering, Asian markets buoy domestic indices  Sify1 week ago Interest-sensitive stocks, derivatives expiry buoy equity markets  Sify3 weeks ago Equities surge on positive global cues, value buying  Sify1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less